polycystic kidney disease, polycystic liver disease
Conditions
Interventions
None listed
Sponsors
Nephrology Center, Toranomon Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with polycystic kidney disease and/or polycystic liver disease.
Exclusion criteria
Exclusion criteria: Patients who are not willing to enroll the study, and those who are considered not eligible to this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| renal failure and survival | — |
Secondary
| Measure | Time frame |
|---|---|
| Change of cystic volume. Incidence of cerebrovascular disease, heart disease, and respiratory disease. | — |
Countries
Japan
Contacts
Public ContactAkinari Sekine
Toranomon Hospital Nephrology Center
Outcome results
None listed